Invasive breast carcinoma

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Jazz Pharmaceuticals Ireland Limited Commercial
    ZANIDATAMAB
    2025-523204-68-00 3 countries 2026 n=100
    Recruiting
  • Institut Jules Bordet Academic
    IMP not specified
    2023-504024-26-00 1 country 2024 n=250
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Jazz Pharmaceuticals Ireland Limited Commercial 1 Phase II 1
Institut Jules Bordet Academic 1 Phase II 1
New trials by year
2024
1
2026
1
← All indication landscapes